The detection of CNVs in cancer research and clinical practice has improved significantly with advances in technology. Techniques such as array-based comparative genomic hybridization (aCGH) and next-generation sequencing (NGS) allow for high-resolution mapping of CNVs across the genome. These methods provide comprehensive insights into the genomic alterations present in cancer cells, enabling better diagnosis and treatment strategies.
